Matching slides 2,665
Current window 2,041-2,070
Pages 89
Rows per page 30
Tool: Problem Statement Canvasclear collectionreset all

Tool

2,041-2,070 of 2,665

filter-aware
22
Includes references to clinical trials (CheckMate 274, AMBASSADOR, NIAGARA) and drug (Imfinzi).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
34
The slide uses a market segmentation approach to map clinical trials (NIAGARA, POTOMAC, VOLGA, NILE) to patient populations (NMIBC, MIBC, 1L mUC).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
05
Uses a structured layout to categorize problems into three pillars: cost/risk, time, and efficacy.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
14
Includes two process diagrams illustrating the Benevolent Platform's role and the experimental validation process.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
23
Includes a reference to Eroom's law, which describes the observation that drug discovery is becoming slower and more expensive over time.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
38
The slide uses a table structure to map initial drivers to resistance mechanisms, supported by clinical citations and microscopy images.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
11
The slide uses a three-column layout to categorize the problem into prevalence, clinical challenges, and patient profile.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
07
Creatd | Investor Presentation Deck | 13 slidesCreatd | Investor Presentation Deck | 13 slides · Creatd
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a series of charts to support the narrative of industry disruption across four key areas.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
44
Eutelsat | Investor Presentation Deck | 55 slidesEutelsat | Investor Presentation Deck | 55 slides · Eutelsat Group
Pitch deck Investor relations 1 hit
24
The slide uses a split layout: left side presents the problem (statistics), right side presents the solution (Just Evotec Biologics' capabilities).Evotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
23
Uses a flywheel-like diagram to represent iterative learning cycles over time.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Aha Moment1 hit
43
Uses a complex heatmap/dot-plot visualization to show drug sensitivity across different samples and cell lines.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
06
Uses a hub-and-spoke diagram to show the central role of freight forwarders as a bottleneck.Freightos | Investor Presentation Deck | 39 slides · Freightos
Pitch deck Investor relations Beat · Problem1 hit
07
Uses a value-chain style diagram to show the flow between carriers, forwarders, and shippers.Freightos | Investor Presentation Deck | 39 slides · Freightos
Pitch deck Investor relations Beat · NeedLoop · Pattern Hunter1 hit
10
The process is presented as a sequential workflow.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
23
The table highlights a statistically significant difference (p=0.0008) in TUSC2 protein expression between SCLC and NSCLC.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
33
Uses an emotional image of a father and child to emphasize the human impact of the disease.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
05
The slide uses a 'why now' framing by highlighting clear consumer demand trends.Grove | Investor Presentation Deck | 33 slides · Grove Collaborative
Pitch deck Investor relations Beat · Early StrugglesLoop · Why Now1 hit
05
The slide uses a 'why now' framing to justify the market opportunity for a sustainable brand.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations 1 hit
43
The slide uses a simple additive structure (A + B) to present two distinct operational improvements.Hugo Boss | Investor Presentation Deck | 99 slides · Hugo Boss
Conference presentation Investor relations Beat · Competition1 hit
48
The slide uses a bubble chart to show clinical trial outcomes and a table to detail efficacy/safety metrics across treatment lines.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
14
The slide highlights the limitations of current first-line azole treatments and identifies a specific patient sub-segment with high unmet need.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a 3x2 matrix structure to contrast clinical efficacy, market opportunity, and current treatment limitations.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Uses a 'before and after' visual comparison of a patient's health progression over time.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Problem Statement1 hit
13
The slide uses a two-column bulleted list to contrast project benefits with the reasons for the pause.Orbia | Investor Presentation Deck | 40 slides · Orbia
Conference presentation Investor relations 1 hit
48
Uses a causal chain visual to link past management issues to current financial underperformance.Starboard Value | Activist Presentation Deck | 71 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
50
Uses a funnel-style process diagram to show the attrition rate of drug compounds.Starboard Value | Activist Presentation Deck | 71 slides · Starboard Value
Activist deck Activist investor Loop · Quick Win Big Bet1 hit
117
Uses a 'problem-solution' structure where the top section identifies failures and the bottom section proposes the Trian Partners solution.Trian Partners | Activist Presentation Deck | 133 slides · Trian Partners
Activist deck Activist investor Beat · Solution (Provide relief)1 hit
11
The slide uses a hub-and-spoke diagram to show the competitive pressure on content owners.ValueAct Capital | Activist Presentation Deck | 19 slides · ValueAct Capital
Activist deck Activist investor 1 hit